Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
At TruLab Dx, we specialize in high-complexity molecular and toxicology diagnostics using RT-PCR, quantitative PCR (qPCR), and LC-MS technologies. Our panels are built for clinical accuracy, rapid turnaround, and actionable insight across a wide range of conditions.
We currently offer diagnostic panels for:
Many of our panels also include antibiotic resistance markers, helping providers identify resistance genes early to support targeted therapy and antimicrobial stewardship.
Each panel is clinically curated to support precision medicine and improved outcomes. Providers gain direct access to our lab team and PharmD consultants for timely, personalized guidance.
Contact us today for more information and to inquire about our other testing panels
Comprehensive RT-PCR testing for rapid detection of bacterial and fungal pathogens causing UTIs. Includes antibiotic resistance markers to support targeted, effective treatment and reduce recurrence.
Our comprehensive STI panel detects a wide range of bacterial, viral, and protozoal pathogens with high accuracy using RT-PCR. This molecular-based approach enables early and reliable detection of infections such as Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Herpes Simplex Virus (HSV), and others. With rapid results and broad coverage, this panel supports timely diagnosis, treatment, and partner management in both acute and asymptomatic cases.
Molecular testing to identify common infectious causes of vaginitis, including bacterial vaginosis, yeast, and trichomoniasis. Results include pathogen-specific detection and co-infection insights to guide precise therapeutic decisions.
Our Mini-RPP uses FDA EUA-authorized RT-PCR technology to rapidly detect key respiratory pathogens with high sensitivity and specificity. Designed for streamlined diagnostics, this panel helps clinicians quickly differentiate between viral and bacterial infections to guide appropriate treatment and infection control. With a focused target set, it supports timely care in both outpatient and long-term care settings - without the delays of broad respiratory panels.
Our advanced wound panel is designed to detect a wide range of pathogens commonly associated with chronic and acute wound infections. Utilizing qPCR and RT-PCR technologies, this panel identifies multidrug-resistant (MDR) organisms, fungal pathogens, and other clinically significant bacteria. It also includes molecular detection of key antibiotic resistance (ABX-R) markers such as mecA (MRSA), blaKPC, ...
Our fungal panel provides precise detection of pathogenic fungi, including yeast species and dermatophytes associated with superficial and systemic infections. Utilizing RT-PCR for rapid and accurate identification, the panel targets clinically significant organisms. Early molecular diagnosis supports targeted antifungal treatment, minimizes diagnostic delays, and improves patient outcomes - especially in immunocompromised or high-risk populations.
Our comprehensive toxicology panel is designed to support accurate detection, monitoring, and compliance management through high-sensitivity LC-MS and qPCR testing. This panel includes a broad range of drug classes and metabolites. This panel supports clinical decision-making for pain management, behavioral health, MAT programs, and post-acute care settings. Custom profiles and frequency options are available based on provider protocols and patient risk levels.
CLIA #05D2183964
Copyright © 2025 TruLab Dx - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.